Deprince Race & Zollo Inc. increased its position in Quanex Building Products Co. (NYSE:NX - Free Report) by 716.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,111,464 shares of the construction company's stock after acquiring an additional 975,324 shares during the quarter. Deprince Race & Zollo Inc. owned about 2.35% of Quanex Building Products worth $26,942,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its position in shares of Quanex Building Products by 30.5% in the third quarter. JPMorgan Chase & Co. now owns 318,044 shares of the construction company's stock valued at $8,826,000 after purchasing an additional 74,396 shares during the period. Pacer Advisors Inc. purchased a new stake in shares of Quanex Building Products during the fourth quarter worth $25,380,000. Barclays PLC grew its position in shares of Quanex Building Products by 391.4% in the third quarter. Barclays PLC now owns 83,794 shares of the construction company's stock valued at $2,325,000 after purchasing an additional 66,742 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Quanex Building Products by 6.4% during the 3rd quarter. Franklin Resources Inc. now owns 19,203 shares of the construction company's stock valued at $562,000 after purchasing an additional 1,150 shares during the period. Finally, Hennessy Advisors Inc. lifted its holdings in Quanex Building Products by 6.8% during the 4th quarter. Hennessy Advisors Inc. now owns 272,618 shares of the construction company's stock worth $6,608,000 after purchasing an additional 17,400 shares in the last quarter. Hedge funds and other institutional investors own 97.48% of the company's stock.
Quanex Building Products Price Performance
NX stock traded down $0.12 during mid-day trading on Friday, reaching $17.22. 269,234 shares of the company traded hands, compared to its average volume of 491,382. The company has a fifty day moving average price of $17.96 and a 200-day moving average price of $22.85. The company has a debt-to-equity ratio of 0.73, a current ratio of 2.24 and a quick ratio of 1.23. Quanex Building Products Co. has a 52-week low of $15.30 and a 52-week high of $35.25. The company has a market capitalization of $812.94 million, a P/E ratio of 15.38, a P/E/G ratio of 0.68 and a beta of 1.01.
Quanex Building Products Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were issued a $0.08 dividend. The ex-dividend date of this dividend was Monday, March 17th. This represents a $0.32 annualized dividend and a dividend yield of 1.86%. Quanex Building Products's payout ratio is currently 52.46%.
Quanex Building Products Company Profile
(
Free Report)
Quanex Building Products Corporation, together with its subsidiaries, provides components for the fenestration industry in the United States, rest of Europe, Canada, Asia, the United Kingdom, and internationally. The company operates through three segments: North American Fenestration, European Fenestration, and North American Cabinet Components.
Further Reading

Before you consider Quanex Building Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quanex Building Products wasn't on the list.
While Quanex Building Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.